Global Pain Management Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • receipt Report ID : 329300
  • calendar_today Published On: Jan, 2023
  • file_copy Pages: 165
  • list Pharmaceuticals and Healthcare
Buy @ $3500

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.

This report is mainly about the drugs for pain management.

According to our latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2022 and is forecast to a readjusted size of USD 45230 million by 2029 with a CAGR of 3.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The leading manufacturers in the industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13.95% and 3.92% of revenues in 2019. By region, the U.S. has the highest share of income, at 49.67 percent in 2019.

This report is a detailed and comprehensive analysis for global Pain Management Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Pain Management Drugs market size and forecasts, in consumption value ($ Million), 2018-2029

Global Pain Management Drugs market size and forecasts by region and country, in consumption value ($ Million), 2018-2029

Global Pain Management Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029

Global Pain Management Drugs market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Pain Management Drugs

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Pain Management Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Pfizer, Grunenthal, Sanofi and Bayer, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Pain Management Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Generic Opioids

Branded Opioids

NSAIDs

Others

Market segment by Application

Hospitals

Drugstores

Others

Market segment by players, this report covers

GSK

Pfizer

Grunenthal

Sanofi

Bayer

AstraZeneca

Eli Lilly

Endo

Merck

Yunnan Baiyao

Teikoku Seiyaku

Teva

J&J

Assertio Therapeutics

Allergan

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Argentina and Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Pain Management Drugs product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Pain Management Drugs, with revenue, gross margin and global market share of Pain Management Drugs from 2018 to 2023.

Chapter 3, the Pain Management Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Pain Management Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War

Chapter 12, the key raw materials and key suppliers, and industry chain of Pain Management Drugs.

Chapter 13, to describe Pain Management Drugs research findings and conclusion.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Pain Management Drugs

1.2 Market Estimation Caveats and Base Year

1.3 Classification of Pain Management Drugs by Type

1.3.1 Overview: Global Pain Management Drugs Market Size by Type: 2018 Versus 2022 Versus 2029

1.3.2 Global Pain Management Drugs Consumption Value Market Share by Type in 2022

1.3.3 Generic Opioids

1.3.4 Branded Opioids

1.3.5 NSAIDs

1.3.6 Others

1.4 Global Pain Management Drugs Market by Application

1.4.1 Overview: Global Pain Management Drugs Market Size by Application: 2018 Versus 2022 Versus 2029

1.4.2 Hospitals

1.4.3 Drugstores

1.4.4 Others

1.5 Global Pain Management Drugs Market Size & Forecast

1.6 Global Pain Management Drugs Market Size and Forecast by Region

1.6.1 Global Pain Management Drugs Market Size by Region: 2018 VS 2022 VS 2029

1.6.2 Global Pain Management Drugs Market Size by Region, (2018-2029)

1.6.3 North America Pain Management Drugs Market Size and Prospect (2018-2029)

1.6.4 Europe Pain Management Drugs Market Size and Prospect (2018-2029)

1.6.5 Asia-Pacific Pain Management Drugs Market Size and Prospect (2018-2029)

1.6.6 South America Pain Management Drugs Market Size and Prospect (2018-2029)

1.6.7 Middle East and Africa Pain Management Drugs Market Size and Prospect (2018-2029)

2 Company Profiles

2.1 GSK

2.1.1 GSK Details

2.1.2 GSK Major Business

2.1.3 GSK Pain Management Drugs Product and Solutions

2.1.4 GSK Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2023)

2.1.5 GSK Recent Developments and Future Plans

2.2 Pfizer

2.2.1 Pfizer Details

2.2.2 Pfizer Major Business

2.2.3 Pfizer Pain Management Drugs Product and Solutions

2.2.4 Pfizer Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2023)

2.2.5 Pfizer Recent Developments and Future Plans

2.3 Grunenthal

2.3.1 Grunenthal Details

2.3.2 Grunenthal Major Business

2.3.3 Grunenthal Pain Management Drugs Product and Solutions

2.3.4 Grunenthal Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2023)

2.3.5 Grunenthal Recent Developments and Future Plans

2.4 Sanofi

2.4.1 Sanofi Details

2.4.2 Sanofi Major Business

2.4.3 Sanofi Pain Management Drugs Product and Solutions

2.4.4 Sanofi Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2023)

2.4.5 Sanofi Recent Developments and Future Plans

2.5 Bayer

2.5.1 Bayer Details

2.5.2 Bayer Major Business

2.5.3 Bayer Pain Management Drugs Product and Solutions

2.5.4 Bayer Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2023)

2.5.5 Bayer Recent Developments and Future Plans

2.6 AstraZeneca

2.6.1 AstraZeneca Details

2.6.2 AstraZeneca Major Business

2.6.3 AstraZeneca Pain Management Drugs Product and Solutions

2.6.4 AstraZeneca Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2023)

2.6.5 AstraZeneca Recent Developments and Future Plans

2.7 Eli Lilly

2.7.1 Eli Lilly Details

2.7.2 Eli Lilly Major Business

2.7.3 Eli Lilly Pain Management Drugs Product and Solutions

2.7.4 Eli Lilly Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2023)

2.7.5 Eli Lilly Recent Developments and Future Plans

2.8 Endo

2.8.1 Endo Details

2.8.2 Endo Major Business

2.8.3 Endo Pain Management Drugs Product and Solutions

2.8.4 Endo Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2023)

2.8.5 Endo Recent Developments and Future Plans

2.9 Merck

2.9.1 Merck Details

2.9.2 Merck Major Business

2.9.3 Merck Pain Management Drugs Product and Solutions

2.9.4 Merck Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2023)

2.9.5 Merck Recent Developments and Future Plans

2.10 Yunnan Baiyao

2.10.1 Yunnan Baiyao Details

2.10.2 Yunnan Baiyao Major Business

2.10.3 Yunnan Baiyao Pain Management Drugs Product and Solutions

2.10.4 Yunnan Baiyao Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2023)

2.10.5 Yunnan Baiyao Recent Developments and Future Plans

2.11 Teikoku Seiyaku

2.11.1 Teikoku Seiyaku Details

2.11.2 Teikoku Seiyaku Major Business

2.11.3 Teikoku Seiyaku Pain Management Drugs Product and Solutions

2.11.4 Teikoku Seiyaku Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2023)

2.11.5 Teikoku Seiyaku Recent Developments and Future Plans

2.12 Teva

2.12.1 Teva Details

2.12.2 Teva Major Business

2.12.3 Teva Pain Management Drugs Product and Solutions

2.12.4 Teva Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2023)

2.12.5 Teva Recent Developments and Future Plans

2.13 J&J

2.13.1 J&J Details

2.13.2 J&J Major Business

2.13.3 J&J Pain Management Drugs Product and Solutions

2.13.4 J&J Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2023)

2.13.5 J&J Recent Developments and Future Plans

2.14 Assertio Therapeutics

2.14.1 Assertio Therapeutics Details

2.14.2 Assertio Therapeutics Major Business

2.14.3 Assertio Therapeutics Pain Management Drugs Product and Solutions

2.14.4 Assertio Therapeutics Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2023)

2.14.5 Assertio Therapeutics Recent Developments and Future Plans

2.15 Allergan

2.15.1 Allergan Details

2.15.2 Allergan Major Business

2.15.3 Allergan Pain Management Drugs Product and Solutions

2.15.4 Allergan Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2023)

2.15.5 Allergan Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Pain Management Drugs Revenue and Share by Players (2018-2023)

3.2 Market Share Analysis (2022)

3.2.1 Market Share of Pain Management Drugs by Company Revenue

3.2.2 Top 3 Pain Management Drugs Players Market Share in 2022

3.2.3 Top 6 Pain Management Drugs Players Market Share in 2022

3.3 Pain Management Drugs Market: Overall Company Footprint Analysis

3.3.1 Pain Management Drugs Market: Region Footprint

3.3.2 Pain Management Drugs Market: Company Product Type Footprint

3.3.3 Pain Management Drugs Market: Company Product Application Footprint

3.4 New Market Entrants and Barriers to Market Entry

3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Pain Management Drugs Consumption Value and Market Share by Type (2018-2023)

4.2 Global Pain Management Drugs Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

5.1 Global Pain Management Drugs Consumption Value Market Share by Application (2018-2023)

5.2 Global Pain Management Drugs Market Forecast by Application (2024-2029)

6 North America

6.1 North America Pain Management Drugs Consumption Value by Type (2018-2029)

6.2 North America Pain Management Drugs Consumption Value by Application (2018-2029)

6.3 North America Pain Management Drugs Market Size by Country

6.3.1 North America Pain Management Drugs Consumption Value by Country (2018-2029)

6.3.2 United States Pain Management Drugs Market Size and Forecast (2018-2029)

6.3.3 Canada Pain Management Drugs Market Size and Forecast (2018-2029)

6.3.4 Mexico Pain Management Drugs Market Size and Forecast (2018-2029)

7 Europe

7.1 Europe Pain Management Drugs Consumption Value by Type (2018-2029)

7.2 Europe Pain Management Drugs Consumption Value by Application (2018-2029)

7.3 Europe Pain Management Drugs Market Size by Country

7.3.1 Europe Pain Management Drugs Consumption Value by Country (2018-2029)

7.3.2 Germany Pain Management Drugs Market Size and Forecast (2018-2029)

7.3.3 France Pain Management Drugs Market Size and Forecast (2018-2029)

7.3.4 United Kingdom Pain Management Drugs Market Size and Forecast (2018-2029)

7.3.5 Russia Pain Management Drugs Market Size and Forecast (2018-2029)

7.3.6 Italy Pain Management Drugs Market Size and Forecast (2018-2029)

8 Asia-Pacific

8.1 Asia-Pacific Pain Management Drugs Consumption Value by Type (2018-2029)

8.2 Asia-Pacific Pain Management Drugs Consumption Value by Application (2018-2029)

8.3 Asia-Pacific Pain Management Drugs Market Size by Region

8.3.1 Asia-Pacific Pain Management Drugs Consumption Value by Region (2018-2029)

8.3.2 China Pain Management Drugs Market Size and Forecast (2018-2029)

8.3.3 Japan Pain Management Drugs Market Size and Forecast (2018-2029)

8.3.4 South Korea Pain Management Drugs Market Size and Forecast (2018-2029)

8.3.5 India Pain Management Drugs Market Size and Forecast (2018-2029)

8.3.6 Southeast Asia Pain Management Drugs Market Size and Forecast (2018-2029)

8.3.7 Australia Pain Management Drugs Market Size and Forecast (2018-2029)

9 South America

9.1 South America Pain Management Drugs Consumption Value by Type (2018-2029)

9.2 South America Pain Management Drugs Consumption Value by Application (2018-2029)

9.3 South America Pain Management Drugs Market Size by Country

9.3.1 South America Pain Management Drugs Consumption Value by Country (2018-2029)

9.3.2 Brazil Pain Management Drugs Market Size and Forecast (2018-2029)

9.3.3 Argentina Pain Management Drugs Market Size and Forecast (2018-2029)

10 Middle East & Africa

10.1 Middle East & Africa Pain Management Drugs Consumption Value by Type (2018-2029)

10.2 Middle East & Africa Pain Management Drugs Consumption Value by Application (2018-2029)

10.3 Middle East & Africa Pain Management Drugs Market Size by Country

10.3.1 Middle East & Africa Pain Management Drugs Consumption Value by Country (2018-2029)

10.3.2 Turkey Pain Management Drugs Market Size and Forecast (2018-2029)

10.3.3 Saudi Arabia Pain Management Drugs Market Size and Forecast (2018-2029)

10.3.4 UAE Pain Management Drugs Market Size and Forecast (2018-2029)

11 Market Dynamics

11.1 Pain Management Drugs Market Drivers

11.2 Pain Management Drugs Market Restraints

11.3 Pain Management Drugs Trends Analysis

11.4 Porters Five Forces Analysis

11.4.1 Threat of New Entrants

11.4.2 Bargaining Power of Suppliers

11.4.3 Bargaining Power of Buyers

11.4.4 Threat of Substitutes

11.4.5 Competitive Rivalry

11.5 Influence of COVID-19 and Russia-Ukraine War

11.5.1 Influence of COVID-19

11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

12.1 Pain Management Drugs Industry Chain

12.2 Pain Management Drugs Upstream Analysis

12.3 Pain Management Drugs Midstream Analysis

12.4 Pain Management Drugs Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Pain Management Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Table 2. Global Pain Management Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029

Table 3. Global Pain Management Drugs Consumption Value by Region (2018-2023) & (USD Million)

Table 4. Global Pain Management Drugs Consumption Value by Region (2024-2029) & (USD Million)

Table 5. GSK Company Information, Head Office, and Major Competitors

Table 6. GSK Major Business

Table 7. GSK Pain Management Drugs Product and Solutions

Table 8. GSK Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 9. GSK Recent Developments and Future Plans

Table 10. Pfizer Company Information, Head Office, and Major Competitors

Table 11. Pfizer Major Business

Table 12. Pfizer Pain Management Drugs Product and Solutions

Table 13. Pfizer Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 14. Pfizer Recent Developments and Future Plans

Table 15. Grunenthal Company Information, Head Office, and Major Competitors

Table 16. Grunenthal Major Business

Table 17. Grunenthal Pain Management Drugs Product and Solutions

Table 18. Grunenthal Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 19. Grunenthal Recent Developments and Future Plans

Table 20. Sanofi Company Information, Head Office, and Major Competitors

Table 21. Sanofi Major Business

Table 22. Sanofi Pain Management Drugs Product and Solutions

Table 23. Sanofi Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 24. Sanofi Recent Developments and Future Plans

Table 25. Bayer Company Information, Head Office, and Major Competitors

Table 26. Bayer Major Business

Table 27. Bayer Pain Management Drugs Product and Solutions

Table 28. Bayer Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 29. Bayer Recent Developments and Future Plans

Table 30. AstraZeneca Company Information, Head Office, and Major Competitors

Table 31. AstraZeneca Major Business

Table 32. AstraZeneca Pain Management Drugs Product and Solutions

Table 33. AstraZeneca Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 34. AstraZeneca Recent Developments and Future Plans

Table 35. Eli Lilly Company Information, Head Office, and Major Competitors

Table 36. Eli Lilly Major Business

Table 37. Eli Lilly Pain Management Drugs Product and Solutions

Table 38. Eli Lilly Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 39. Eli Lilly Recent Developments and Future Plans

Table 40. Endo Company Information, Head Office, and Major Competitors

Table 41. Endo Major Business

Table 42. Endo Pain Management Drugs Product and Solutions

Table 43. Endo Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 44. Endo Recent Developments and Future Plans

Table 45. Merck Company Information, Head Office, and Major Competitors

Table 46. Merck Major Business

Table 47. Merck Pain Management Drugs Product and Solutions

Table 48. Merck Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 49. Merck Recent Developments and Future Plans

Table 50. Yunnan Baiyao Company Information, Head Office, and Major Competitors

Table 51. Yunnan Baiyao Major Business

Table 52. Yunnan Baiyao Pain Management Drugs Product and Solutions

Table 53. Yunnan Baiyao Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 54. Yunnan Baiyao Recent Developments and Future Plans

Table 55. Teikoku Seiyaku Company Information, Head Office, and Major Competitors

Table 56. Teikoku Seiyaku Major Business

Table 57. Teikoku Seiyaku Pain Management Drugs Product and Solutions

Table 58. Teikoku Seiyaku Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 59. Teikoku Seiyaku Recent Developments and Future Plans

Table 60. Teva Company Information, Head Office, and Major Competitors

Table 61. Teva Major Business

Table 62. Teva Pain Management Drugs Product and Solutions

Table 63. Teva Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 64. Teva Recent Developments and Future Plans

Table 65. J&J Company Information, Head Office, and Major Competitors

Table 66. J&J Major Business

Table 67. J&J Pain Management Drugs Product and Solutions

Table 68. J&J Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 69. J&J Recent Developments and Future Plans

Table 70. Assertio Therapeutics Company Information, Head Office, and Major Competitors

Table 71. Assertio Therapeutics Major Business

Table 72. Assertio Therapeutics Pain Management Drugs Product and Solutions

Table 73. Assertio Therapeutics Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 74. Assertio Therapeutics Recent Developments and Future Plans

Table 75. Allergan Company Information, Head Office, and Major Competitors

Table 76. Allergan Major Business

Table 77. Allergan Pain Management Drugs Product and Solutions

Table 78. Allergan Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 79. Allergan Recent Developments and Future Plans

Table 80. Global Pain Management Drugs Revenue (USD Million) by Players (2018-2023)

Table 81. Global Pain Management Drugs Revenue Share by Players (2018-2023)

Table 82. Breakdown of Pain Management Drugs by Company Type (Tier 1, Tier 2, and Tier 3)

Table 83. Market Position of Players in Pain Management Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022

Table 84. Head Office of Key Pain Management Drugs Players

Table 85. Pain Management Drugs Market: Company Product Type Footprint

Table 86. Pain Management Drugs Market: Company Product Application Footprint

Table 87. Pain Management Drugs New Market Entrants and Barriers to Market Entry

Table 88. Pain Management Drugs Mergers, Acquisition, Agreements, and Collaborations

Table 89. Global Pain Management Drugs Consumption Value (USD Million) by Type (2018-2023)

Table 90. Global Pain Management Drugs Consumption Value Share by Type (2018-2023)

Table 91. Global Pain Management Drugs Consumption Value Forecast by Type (2024-2029)

Table 92. Global Pain Management Drugs Consumption Value by Application (2018-2023)

Table 93. Global Pain Management Drugs Consumption Value Forecast by Application (2024-2029)

Table 94. North America Pain Management Drugs Consumption Value by Type (2018-2023) & (USD Million)

Table 95. North America Pain Management Drugs Consumption Value by Type (2024-2029) & (USD Million)

Table 96. North America Pain Management Drugs Consumption Value by Application (2018-2023) & (USD Million)

Table 97. North America Pain Management Drugs Consumption Value by Application (2024-2029) & (USD Million)

Table 98. North America Pain Management Drugs Consumption Value by Country (2018-2023) & (USD Million)

Table 99. North America Pain Management Drugs Consumption Value by Country (2024-2029) & (USD Million)

Table 100. Europe Pain Management Drugs Consumption Value by Type (2018-2023) & (USD Million)

Table 101. Europe Pain Management Drugs Consumption Value by Type (2024-2029) & (USD Million)

Table 102. Europe Pain Management Drugs Consumption Value by Application (2018-2023) & (USD Million)

Table 103. Europe Pain Management Drugs Consumption Value by Application (2024-2029) & (USD Million)

Table 104. Europe Pain Management Drugs Consumption Value by Country (2018-2023) & (USD Million)

Table 105. Europe Pain Management Drugs Consumption Value by Country (2024-2029) & (USD Million)

Table 106. Asia-Pacific Pain Management Drugs Consumption Value by Type (2018-2023) & (USD Million)

Table 107. Asia-Pacific Pain Management Drugs Consumption Value by Type (2024-2029) & (USD Million)

Table 108. Asia-Pacific Pain Management Drugs Consumption Value by Application (2018-2023) & (USD Million)

Table 109. Asia-Pacific Pain Management Drugs Consumption Value by Application (2024-2029) & (USD Million)

Table 110. Asia-Pacific Pain Management Drugs Consumption Value by Region (2018-2023) & (USD Million)

Table 111. Asia-Pacific Pain Management Drugs Consumption Value by Region (2024-2029) & (USD Million)

Table 112. South America Pain Management Drugs Consumption Value by Type (2018-2023) & (USD Million)

Table 113. South America Pain Management Drugs Consumption Value by Type (2024-2029) & (USD Million)

Table 114. South America Pain Management Drugs Consumption Value by Application (2018-2023) & (USD Million)

Table 115. South America Pain Management Drugs Consumption Value by Application (2024-2029) & (USD Million)

Table 116. South America Pain Management Drugs Consumption Value by Country (2018-2023) & (USD Million)

Table 117. South America Pain Management Drugs Consumption Value by Country (2024-2029) & (USD Million)

Table 118. Middle East & Africa Pain Management Drugs Consumption Value by Type (2018-2023) & (USD Million)

Table 119. Middle East & Africa Pain Management Drugs Consumption Value by Type (2024-2029) & (USD Million)

Table 120. Middle East & Africa Pain Management Drugs Consumption Value by Application (2018-2023) & (USD Million)

Table 121. Middle East & Africa Pain Management Drugs Consumption Value by Application (2024-2029) & (USD Million)

Table 122. Middle East & Africa Pain Management Drugs Consumption Value by Country (2018-2023) & (USD Million)

Table 123. Middle East & Africa Pain Management Drugs Consumption Value by Country (2024-2029) & (USD Million)

Table 124. Pain Management Drugs Raw Material

Table 125. Key Suppliers of Pain Management Drugs Raw Materials

List of Figures

Figure 1. Pain Management Drugs Picture

Figure 2. Global Pain Management Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Figure 3. Global Pain Management Drugs Consumption Value Market Share by Type in 2022

Figure 4. Generic Opioids

Figure 5. Branded Opioids

Figure 6. NSAIDs

Figure 7. Others

Figure 8. Global Pain Management Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Figure 9. Pain Management Drugs Consumption Value Market Share by Application in 2022

Figure 10. Hospitals Picture

Figure 11. Drugstores Picture

Figure 12. Others Picture

Figure 13. Global Pain Management Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029

Figure 14. Global Pain Management Drugs Consumption Value and Forecast (2018-2029) & (USD Million)

Figure 15. Global Market Pain Management Drugs Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)

Figure 16. Global Pain Management Drugs Consumption Value Market Share by Region (2018-2029)

Figure 17. Global Pain Management Drugs Consumption Value Market Share by Region in 2022

Figure 18. North America Pain Management Drugs Consumption Value (2018-2029) & (USD Million)

Figure 19. Europe Pain Management Drugs Consumption Value (2018-2029) & (USD Million)

Figure 20. Asia-Pacific Pain Management Drugs Consumption Value (2018-2029) & (USD Million)

Figure 21. South America Pain Management Drugs Consumption Value (2018-2029) & (USD Million)

Figure 22. Middle East and Africa Pain Management Drugs Consumption Value (2018-2029) & (USD Million)

Figure 23. Global Pain Management Drugs Revenue Share by Players in 2022

Figure 24. Pain Management Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022

Figure 25. Global Top 3 Players Pain Management Drugs Market Share in 2022

Figure 26. Global Top 6 Players Pain Management Drugs Market Share in 2022

Figure 27. Global Pain Management Drugs Consumption Value Share by Type (2018-2023)

Figure 28. Global Pain Management Drugs Market Share Forecast by Type (2024-2029)

Figure 29. Global Pain Management Drugs Consumption Value Share by Application (2018-2023)

Figure 30. Global Pain Management Drugs Market Share Forecast by Application (2024-2029)

Figure 31. North America Pain Management Drugs Consumption Value Market Share by Type (2018-2029)

Figure 32. North America Pain Management Drugs Consumption Value Market Share by Application (2018-2029)

Figure 33. North America Pain Management Drugs Consumption Value Market Share by Country (2018-2029)

Figure 34. United States Pain Management Drugs Consumption Value (2018-2029) & (USD Million)

Figure 35. Canada Pain Management Drugs Consumption Value (2018-2029) & (USD Million)

Figure 36. Mexico Pain Management Drugs Consumption Value (2018-2029) & (USD Million)

Figure 37. Europe Pain Management Drugs Consumption Value Market Share by Type (2018-2029)

Figure 38. Europe Pain Management Drugs Consumption Value Market Share by Application (2018-2029)

Figure 39. Europe Pain Management Drugs Consumption Value Market Share by Country (2018-2029)

Figure 40. Germany Pain Management Drugs Consumption Value (2018-2029) & (USD Million)

Figure 41. France Pain Management Drugs Consumption Value (2018-2029) & (USD Million)

Figure 42. United Kingdom Pain Management Drugs Consumption Value (2018-2029) & (USD Million)

Figure 43. Russia Pain Management Drugs Consumption Value (2018-2029) & (USD Million)

Figure 44. Italy Pain Management Drugs Consumption Value (2018-2029) & (USD Million)

Figure 45. Asia-Pacific Pain Management Drugs Consumption Value Market Share by Type (2018-2029)

Figure 46. Asia-Pacific Pain Management Drugs Consumption Value Market Share by Application (2018-2029)

Figure 47. Asia-Pacific Pain Management Drugs Consumption Value Market Share by Region (2018-2029)

Figure 48. China Pain Management Drugs Consumption Value (2018-2029) & (USD Million)

Figure 49. Japan Pain Management Drugs Consumption Value (2018-2029) & (USD Million)

Figure 50. South Korea Pain Management Drugs Consumption Value (2018-2029) & (USD Million)

Figure 51. India Pain Management Drugs Consumption Value (2018-2029) & (USD Million)

Figure 52. Southeast Asia Pain Management Drugs Consumption Value (2018-2029) & (USD Million)

Figure 53. Australia Pain Management Drugs Consumption Value (2018-2029) & (USD Million)

Figure 54. South America Pain Management Drugs Consumption Value Market Share by Type (2018-2029)

Figure 55. South America Pain Management Drugs Consumption Value Market Share by Application (2018-2029)

Figure 56. South America Pain Management Drugs Consumption Value Market Share by Country (2018-2029)

Figure 57. Brazil Pain Management Drugs Consumption Value (2018-2029) & (USD Million)

Figure 58. Argentina Pain Management Drugs Consumption Value (2018-2029) & (USD Million)

Figure 59. Middle East and Africa Pain Management Drugs Consumption Value Market Share by Type (2018-2029)

Figure 60. Middle East and Africa Pain Management Drugs Consumption Value Market Share by Application (2018-2029)

Figure 61. Middle East and Africa Pain Management Drugs Consumption Value Market Share by Country (2018-2029)

Figure 62. Turkey Pain Management Drugs Consumption Value (2018-2029) & (USD Million)

Figure 63. Saudi Arabia Pain Management Drugs Consumption Value (2018-2029) & (USD Million)

Figure 64. UAE Pain Management Drugs Consumption Value (2018-2029) & (USD Million)

Figure 65. Pain Management Drugs Market Drivers

Figure 66. Pain Management Drugs Market Restraints

Figure 67. Pain Management Drugs Market Trends

Figure 68. Porters Five Forces Analysis

Figure 69. Manufacturing Cost Structure Analysis of Pain Management Drugs in 2022

Figure 70. Manufacturing Process Analysis of Pain Management Drugs

Figure 71. Pain Management Drugs Industrial Chain

Figure 72. Methodology

Figure 73. Research Process and Data Source